Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00252876

Public ClinicalTrials.gov record NCT00252876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.

Study identification

NCT ID
NCT00252876
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
2,000 participants

Conditions and interventions

Interventions

  • tesaglitazar Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Mar 16, 2008

2005 – 2007

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
58
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Columbiana Alabama
Research Site Mobile Alabama
Research Site Carlisle Arkansas
Research Site Sherwood Arkansas
Research Site Chula Vista California
Research Site Escondido California
Research Site Huntington Beach California
Research Site Los Angeles California
Research Site Mission Viejo California
Research Site Orange California
Research Site Pasadena California
Research Site Redondo Beach California
Research Site Sacramento California
Research Site Colorado Springs Colorado
Research Site Wheat Ridge Colorado
Research Site Clearwater Florida
Research Site Gainesville Florida
Research Site Hollywood Florida
Research Site Jacksonville Florida
Research Site Miami Florida
Research Site West Palm Beach Florida
Research Site Atlanta Georgia
Research Site Brunswick Georgia
Research Site Honolulu Hawaii
Research Site Boise Idaho
Research Site Evansville Indiana
Research Site Witchita Kansas
Research Site Bossier City Louisiana
Research Site New Orleans Louisiana
Research Site Baltimore Maryland
Research Site Kalamazoo Michigan
Research Site Las Vegas Nevada
Research Site Pahrump Nevada
Research Site Hamilton New Jersey
Research Site Albuquerque New Mexico
Research Site New York New York
Research Site Rochester New York
Research Site The Bronx New York
Research Site White Plains New York
Research Site Charlotte North Carolina
Research Site Cincinnati Ohio
Research Site Dayton Ohio
Research Site Kettering Ohio
Research Site Oklahoma City Oklahoma
Research Site Medford Oregon
Research Site Philadelphia Pennsylvania
Research Site Simpsonville South Carolina
Research Site Morristown Tennessee
Research Site Corpus Christi Texas
Research Site Dallas Texas
Research Site San Antonio Texas
Research Site Burke Virginia
Research Site Norfolk Virginia
Research Site Richmond Virginia
Research Site Tacoma Washington
Research Site Menomonee Falls Wisconsin
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 219 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00252876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2008 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00252876 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →